Daridorexant ema approval date european union quviviq insomnia?

Quviviq (daridorexant) received EU-wide marketing authorization from the European Commission in March 2022 for the treatment of insomnia in adults.

For context, the US FDA approved daridorexant in January 2022. If you’d like, I can share the CHMP opinion date and the exact EC approval date.